We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+2.41%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$8.93B
AUM Growth
+$814M
Cap. Flow
+$728M
Cap. Flow %
8.15%
Top 10 Hldgs %
12.09%
Holding
2,052
New
174
Increased
1,355
Reduced
425
Closed
84

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$24.5M
2
IBM icon
IBM
IBM
+$18M
3
AAPL icon
Apple
AAPL
+$15.5M
4
SNY icon
Sanofi
SNY
+$13.7M
5
AGN
Allergan plc
AGN
+$13.6M

Sector Composition

Rank Sector Weight
1 Financials 17.05%
2 Healthcare 15.22%
3 Technology 14.48%
4 Industrials 8.72%
5 Consumer Staples 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
51
Bristol-Myers Squibb
BMY
$129B
$32.5M 0.36%
504,026
+43,606
+9% +$2.73M
BNS icon
52
Scotiabank
BNS
$105B
$32.4M 0.36%
682,541
+192,925
+39% +$9.42M
CB icon
53
Chubb
CB
$140B
$32.4M 0.36%
290,908
+34,215
+13% +$3.85M
CHT icon
54
Chunghwa Telecom
CHT
$33.5B
$32.4M 0.36%
1,008,737
+135,924
+16% +$4.17M
ADP icon
55
Automatic Data Processing
ADP
$109B
$32.3M 0.36%
376,969
+39,756
+12% +$3.42M
CHL
56
DELISTED
China Mobile Limited
CHL
$32.3M 0.36%
496,266
-11,022
-2% -$719K
USB icon
57
US Bancorp
USB
$97.9B
$32M 0.36%
732,256
+45,388
+7% +$1.99M
RY icon
58
Royal Bank of Canada
RY
$287B
$31M 0.35%
514,264
+85,685
+20% +$5.27M
CELG
59
DELISTED
Celgene Corp
CELG
$30.7M 0.34%
265,910
+23,002
+9% +$2.75M
AZN icon
60
AstraZeneca
AZN
$269B
$30.6M 0.34%
446,802
+51,640
+13% +$3.59M
TD icon
61
Toronto Dominion Bank
TD
$193B
$30.4M 0.34%
708,635
-4,979
-0.7% -$214K
NKE icon
62
Nike
NKE
$64.1B
$30.2M 0.34%
601,262
+39,866
+7% +$1.91M
BA icon
63
Boeing
BA
$169B
$30.2M 0.34%
200,924
+15,679
+8% +$2.28M
SNY icon
64
Sanofi
SNY
$107B
$30.1M 0.34%
608,964
+287,022
+89% +$13.7M
DCM
65
DELISTED
NTT DOCOMO, Inc.
DCM
$30M 0.34%
1,718,518
+225,286
+15% +$3.88M
AGN
66
DELISTED
Allergan plc
AGN
$27.6M 0.31%
92,650
+47,680
+106% +$13.6M
AFL icon
67
Aflac
AFL
$65.5B
$27.5M 0.31%
859,418
+165,554
+24% +$5.05M
SLB icon
68
SLB Ltd
SLB
$72.7B
$27.3M 0.31%
327,379
+23,463
+8% +$1.95M
COST icon
69
Costco
COST
$432B
$27.1M 0.3%
178,966
+11,928
+7% +$1.75M
HMC icon
70
Honda
HMC
$39.8B
$26.9M 0.3%
822,162
+184,002
+29% +$5.93M
LLY icon
71
Eli Lilly
LLY
$1.08T
$26.8M 0.3%
368,992
+52,107
+16% +$3.71M
MA icon
72
Mastercard
MA
$498B
$26.5M 0.3%
306,254
+15,979
+6% +$1.39M
ABBV icon
73
AbbVie
ABBV
$465B
$26.3M 0.29%
449,577
+21,317
+5% +$1.29M
HON icon
74
Honeywell
HON
$76.4B
$26.2M 0.29%
279,144
+24,451
+10% +$2.24M
ACN icon
75
Accenture
ACN
$106B
$26M 0.29%
277,902
+20,957
+8% +$1.87M

Similar funds

Aperio Group's Q1 2015 Portfolio in Review

As of Q1 2015, Aperio Group held 2,052 positions worth $8.93B, up 10% from $8.11B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Aperio Group deployed $728M of net new capital in Q1 2015, opening 174 new positions and adding to 1,355 existing holdings. Its largest new stake was Paramount Group: 95,957 shares worth $1.85M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Royal Dutch Shell PLC ADS Class A, an estimated $6.37M trimmed.

  • Aperio Group's largest Q1 2015 buy was Paramount Group: 95,957 shares worth $1.85M.
  • Aperio Group added most to Starbucks in Q1 2015, an estimated $24.5M increase.
  • Aperio Group's biggest Q1 2015 reduction was Royal Dutch Shell PLC ADS Class A, cutting an estimated $6.37M.
  • Aperio Group fully exited Allergan Inc in Q1 2015, selling an estimated $20.2M.
  • Aperio Group's ten largest holdings make up 12% of its $8.93B portfolio in Q1 2015.
  • Aperio Group opened 174 new positions and closed 84 in Q1 2015.
  • Aperio Group's portfolio value rose 10% quarter-over-quarter to $8.93B.

Based on Aperio Group's 13F filing for Q1 2015, filed 29 Apr 2015.